应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02186 绿叶制药
已收盘 05-06 16:08:10
2.540
+0.010
+0.40%
最高
2.580
最低
2.530
成交量
1,871万
今开
2.540
昨收
2.530
日振幅
1.98%
总市值
101.47亿
流通市值
101.47亿
总股本
39.95亿
成交额
4,775万
换手率
0.47%
流通股本
39.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%
公告速递 · 04-29
绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组
智通财经 · 04-20
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
智通财经 · 04-16
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-15
绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组
【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量
金吾财讯 · 04-15
【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量
大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级
中金财经 · 04-14
大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级
港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-14
港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元
智通财经 · 04-13
瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元
绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-08
绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
绿叶制药2026年3月股份变动月报表,股本维持不变
公告速递 · 04-08
绿叶制药2026年3月股份变动月报表,股本维持不变
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
格隆汇 · 04-02
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%
异动解读 · 04-02
异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%
港股异动 | 绿叶制药(02186)涨近5% 2025年股东应占溢利同比增长31.12%
智通财经 · 04-02
港股异动 | 绿叶制药(02186)涨近5% 2025年股东应占溢利同比增长31.12%
绿叶制药:2025年净利润同比增长9.4%
南方财经网 · 03-31
绿叶制药:2025年净利润同比增长9.4%
绿叶制药(02186.HK)拟3月30日举行董事会会议审批年度业绩
中金财经 · 03-17
绿叶制药(02186.HK)拟3月30日举行董事会会议审批年度业绩
每日卖空追踪 | 绿叶制药 03月13日卖空量成交77.85万股,卖空比例为5.87%
市场透视 · 03-13
每日卖空追踪 | 绿叶制药 03月13日卖空量成交77.85万股,卖空比例为5.87%
绿叶制药03月13日遭主力抛售514.7万元
市场透视 · 03-13
绿叶制药03月13日遭主力抛售514.7万元
每日卖空追踪 | 绿叶制药 03月09日卖空量成交56.65万股,卖空比例为2.26%
市场透视 · 03-09
每日卖空追踪 | 绿叶制药 03月09日卖空量成交56.65万股,卖空比例为2.26%
绿叶制药03月09日遭主力抛售946.2万元
市场透视 · 03-09
绿叶制药03月09日遭主力抛售946.2万元
绿叶制药03月03日遭主力抛售412.2万元
市场透视 · 03-03
绿叶制药03月03日遭主力抛售412.2万元
加载更多
公司概况
公司名称:
绿叶制药
所属市场:
SEHK
上市日期:
--
主营业务:
绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。
发行价格:
--
{"stockData":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"绿叶制药","latestPrice":2.54,"timestamp":1778054890006,"preClose":2.53,"halted":0,"volume":18710000,"delay":0,"changeRate":0.003952569169960566,"floatShares":3995000000,"shares":3995000000,"eps":0.1828071783433501,"marketStatus":"已收盘","change":0.01,"latestTime":"05-06 16:08:10","open":2.54,"high":2.58,"low":2.53,"amount":47754385,"amplitude":0.019763,"askPrice":2.55,"askSize":397000,"bidPrice":2.54,"bidSize":48500,"shortable":3,"etf":0,"ttmEps":0.1828071783433501,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778117400000},"marketStatusCode":5,"adr":0,"listingDate":1404835200000,"exchange":"SEHK","adjPreClose":2.53,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":1.641472,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02186","defaultTab":"news","newsList":[{"id":"1144597396","title":"绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144597396","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144597396?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:12","pubTimestamp":1777471967,"startTime":"0","endTime":"0","summary":"绿叶制药在报告期内实现收入人民币63.08亿元,同比上升4.1%,主要得益于部分核心产品销售扩大及授权品种贡献。年内整体盈利保持增长,母公司拥有人应占溢利为人民币6.19亿元,同比提升31.1%;集团年内溢利达到人民币7.06亿元,同比上升9.4%。经调整后,除税前溢利录得人民币9.45亿元,同比增长12.6%;EBITDA为人民币24.71亿元,同比增长12.7%。毛利总额约人民币41.63亿元,毛利率为66.0%,较上一年度略有回落但仍维持稳健水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728871","title":"绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728871","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628728871?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:09","pubTimestamp":1776686941,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主研发的新分子实体LY03015的美国药代动力学桥接临床试验已完成首例受试者入组。LY03015为全球首个囊泡单胺转运体2 抑制剂和σ-1受体激动剂,目标适应症为治疗迟发性运动障碍和亨廷顿病。LY03015通过靶向VMAT2和Sigma-1R,旨在发挥对于TD和HD两种疾病在“症状控制”和“病理改善”的双重作用。据集团所知,VMAT2抑制剂是目前唯一一类获得美国食品药品监督管理局批准上市的、用于治疗TD和HD的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK4181","PK","03015","159992","BK4218","BK1583","BK1191","06978","BK1574","02186","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627254292","title":"港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627254292","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627254292?lang=zh_cn&edition=full","pubTime":"2026-04-16 09:01","pubTimestamp":1776301266,"startTime":"0","endTime":"0","summary":"【重大事项】宁德时代(03750)拟投资 300 亿元设立全资子公司 打造新能源矿产平台美格智能(03268)拟投资3亿元于AI研发及先进制造产业项目并签署投资协议力勤资源(02245):印尼镍矿政策变动不影响正常经营 与合作伙伴保持良好合作关系确保Obi项目稳定运行中远海能(01138)拟10.18亿元建造两艘巴拿马型原油轮荣昌生物(09995):收到艾伯维就RC148独家授权许可协议支付的6.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"05d74946e1a2924d42dd26ed36b9a988","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823038988.USD","LU2506952337.HKD","LU0359201612.USD","LU0449515922.USD","LU1188198961.HKD","HK0000181138.USD","LU1978683503.SGD","LU2298322129.HKD","LU0345776255.USD","LU1008478684.HKD","IE00B3M56506.USD","SG9999001689.USD","LU1064131003.USD","LU0320764755.SGD","LU2348773727.SGD","LU2476274720.SGD","LU0320764599.SGD","LU0235996351.USD","00300","LU0593848301.USD","300433","IE0003795394.USD","LU2153592121.USD","SG9999000327.SGD","LU0164880469.USD","BK1618","LU0051755006.USD","LU2424517915.HKD","LU0561508036.HKD","LU0326948709.USD","LU1993786604.SGD","LU0214875030.USD","BK1610","600115","LU0499858602.USD","LU1152091754.HKD","LU1769817096.USD","LU1242518857.USD","01093","LU0327786744.USD","LU0039217434.USD","SGXZ81163826.USD","LU0651947912.USD","LU2298064838.USD","HK0000165453.HKD","LU0828237510.HKD","LU0797268264.HKD","LU0611395673.USD","SG9999000459.SGD","SBHMY","LU2399975544.HKD","LU1152091168.USD","LU2097828557.USD","BK1193","LU0594300179.USD","LU0228659784.USD","LU1051769294.HKD","IE0034224299.USD","LU0326950275.SGD","LU0244354667.USD","LU0054450605.USD","LU1831875114.USD","LU0149721374.USD","LU0516423091.SGD","BK1521","LU0823426480.USD","LU0164865239.USD","LU0164872284.USD","LU2294711473.HKD","LU1102505929.USD","LU0509642566.USD","LU1868838027.USD","LU2226246903.HKD","LU0169518387.USD","LU1861219969.SGD","LU0823413660.USD","LU1880383366.USD","01177","LU0359201885.HKD","LU0043850808.USD","03908","02556","LU0140636845.USD","LU0469268626.HKD","LU0124384867.USD","02186","06656","LU1939255532.USD","LU0188438112.USD","SGXZ49509284.SGD","LU0823397103.USD","LU0828238088.HKD","LU1048596156.SGD","LU1807302812.USD","IE0032431581.USD","01810","LU2477742899.HKD","LU0455707207.USD","BK1523","BK1535","LU0143863198.USD","LU2348774022.SGD","IE00B29SXG58.USD","SG9999001846.SGD","81810","LU0269904917.USD","LU0441854154.USD","LU1861214812.USD","300750","LU0821914370.USD","LU1328277881.USD","LU1719994722.HKD","LU1769817179.HKD","02245","LU0405327148.USD","LU2580892789.USD","LU0128522157.USD","LU1820825898.SGD","LU0210526637.USD","LU0405327494.USD","LU0708995583.HKD","HK0000286598.CNH","LU1720050803.USD","LU0261950470.USD","BK1502","SG9999002463.SGD","LU1102505762.USD","LU1781817850.SGD","LU1048588211.SGD","LU1997245177.USD","LU2506952410.USD","LU2039709279.SGD","LU0823426308.USD","LU0607220059.USD","LU0634319403.HKD","LU2097828631.EUR","LU2357125470.USD","LU1794554557.SGD","LU0106959298.USD","LU0067412154.USD","LU0117841782.USD","09995","LU0181495838.USD","LU1051768304.USD","LU1146622755.USD","LU1251922891.USD","LU0823039010.USD","LU0314109678.HKD","02038","EVS.SI","LU0823040885.USD","XIACY","LU0463099449.HKD","LU0823397285.USD","LU0107464264.USD","LU2045819591.USD","BK1166","LU0456846285.SGD","LU0251143458.SGD","LU1960683339.HKD","LU1997245094.SGD","IE00BZ199S13.USD","IE00BD6J9T35.USD","01138","LU2495084118.USD","LU0029875118.USD","LU0302445910.USD","LU1039395188.USD","LU1580142542.USD","LU0823041008.USD","LU0345775950.USD","LU2328871848.SGD","LU0231483743.USD","LU0084288322.USD","LU0254981946.USD","LU2506952253.HKD","LU0370786039.SGD","LU1770034418.SGD","LU0106259558.USD","LU1303224171.USD","688331","LU0417516738.SGD","LU1956131251.USD","LU2580892862.HKD","LU1961090484.USD","000333","LU2506951792.HKD","BK4526","LU0049853897.USD","LU0531971595.HKD","IE00B8HQ1Z84.USD","BK1149","LU0823414551.USD","LU1981816686.USD","LU1655091616.SGD","LU0543330483.HKD","LU0211977185.USD","BK1116","LU2449936058.SGD","LU0348827113.USD","LU1979443071.USD","LU0651946864.USD","LU0823414478.USD","LU2476274308.USD","LU1515016050.SGD","LU2097828805.USD","LU0672654166.SGD","LU2125910849.SGD","LU0572944931.SGD","LU1255011170.USD","06936","LU1969619763.USD","LU0456827905.SGD","LU1023057109.AUD","LU0499858438.USD","LU0516422440.USD","LU0052750758.USD","LU0165289439.USD","LU0348816934.USD","LU0106252389.USD","LU0516422952.EUR","LU0516423174.USD","LU0328353924.USD","002881","SG9999001903.USD","CCOZY","600026","LU0048388663.USD","LU0359202008.SGD","LU0501845795.SGD","603906","BK4141","LU0149534421.HKD","LU0588546209.SGD","LU0823437842.USD","LU2153591404.USD","LU1105468828.SGD","LU0724618433.USD","LU1868837565.USD","LU0540923850.HKD","LU1934453819.USD","IE00B543WZ88.USD","LU0979878070.USD","LU0348735423.USD","LU2257852520.SGD","LU0417516902.SGD","LU0880133367.SGD","LU0605514214.HKD","02465","LU2275660780.HKD","LU1282648689.USD","LU0918141705.HKD","HXXD.SI","LU0449509016.USD","00753","BK1575","06613","00670","LU0871576103.HKD","IE00B5MMRT66.SGD","LU0531970944.HKD","LU1721428347.USD","002352","LU0143863784.USD","LU0259732245.USD","LU0700851271.USD","LU0011963245.USD","IE00BPRC5H50.USD","SG9999003461.SGD","LU2249611893.SGD","LU1242518931.SGD","LU1880383440.USD","LU0650527681.SGD","BK0224","LU0312595415.SGD","LU0307460666.USD","LU0505663152.USD","BK1506","BK4585","03268","LU0594300419.USD","LU2360107325.USD","LU2152927971.USD","LU0348805143.USD","LU2097828714.EUR","BK4519","LU0828237940.HKD","LU0047713382.USD","LU0502904849.HKD","LU0675040207.SGD","LU2238339852.HKD","BK1607","LU0072913022.USD","LU3063872942.SGD","LU0348814723.USD","BK1615","LU2289578879.USD","SG9999001093.SGD","LU0048575426.USD","SG9999002828.SGD","LU2294711713.HKD","LU1808992512.USD","LU0918141887.USD","LU2778985437.USD","LU2125910500.SGD","LU1997244956.HKD","HK0000181112.HKD","LU0516422366.SGD","LU1323998911.USD","03750","LU2087589342.USD","LU0823413587.USD","601898","LU0132412106.USD","01898","LU2148510915.USD","LU0072462343.USD","601111","LU1813983027.USD","IE0003851619.USD","601995","LU0192582467.USD","LU1064130708.USD","LU0348825331.USD","LU1770036033.HKD","FXCNY","LU0048580855.USD","IE00B8L5B284.USD","LU2097828474.EUR","BK1589","LU1481107354.HKD","SG9999014674.SGD","LU2242644610.SGD","08279","02298","MIUmain","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627335287","title":"绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2627335287","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627335287?lang=zh_cn&edition=full","pubTime":"2026-04-15 21:03","pubTimestamp":1776258221,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主研发的创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验已完成首例受试者入组。此次开展的中国Ⅱ期临床试验为一项随机、双盲、平行、安慰剂对照研究,旨在评估LY03017治疗阿尔茨海默病精神病性障碍相关幻觉和妄想的初步疗效和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","159992","BK1583","BK1191","06978","BK1574","02186","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407443","title":"【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407443","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627407443?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:07","pubTimestamp":1776244030,"startTime":"0","endTime":"0","summary":"金吾财讯 | 东北证券发布研报指,绿叶制药 2025年业绩显示盈利能力稳健提升,新产品加速放量,在研管线陆续进入收获期,首次覆盖给予“增持”评级。2025年新产品销售额同比增长56.8%,占产品销售收入总额比例近30%。CNS领域,全球首创药物LY03015中国2期临床即将结束,美国PK桥接试验已启动;LY03017、LY03020均已在中国进入2期临床并在美国获IND批准。报告指出,公司在研管线横跨CNS、肿瘤、自免,2026年有望进入收获期。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979035","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","000686"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627878492","title":"大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627878492","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627878492?lang=zh_cn&edition=full","pubTime":"2026-04-14 13:47","pubTimestamp":1776145622,"startTime":"0","endTime":"0","summary":"花旗发表研报指,绿叶制药管理层指引2026年至2030年纯利复合年均增长率(CAGR)超过25%,这意味着盈利将显著改善,主要受惠于:旗下产品Erozfi在美国的销售加速增长,预计2026年销售额将翻倍至4000万美元并达到收支平衡;中国新产品持续增长。花旗基于现金流折现(DCF)估值法,将集团目标价由5港元降至4.3港元,重申“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260414/32142092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02186","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627983499","title":"港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2627983499","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627983499?lang=zh_cn&edition=full","pubTime":"2026-04-14 11:54","pubTimestamp":1776138882,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,绿叶制药午前涨近3%,截至发稿,涨2.52%,报2.85港元,成交额5323.6万港元。消息面上,近日,绿叶制药发布公告,本集团自主研发的创新药LY03020的中国Ⅱ期临床已完成首例患者入组。此前,LY03020亦已在美国获准开展临床试验,是本集团在中国和海外同步开发的又一款中枢神经系统治疗领域的创新药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4588","BK1606","BK4585","159992","06978","02186","BK1583","BK1161","VXUS","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627372437","title":"瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627372437","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627372437?lang=zh_cn&edition=full","pubTime":"2026-04-13 19:20","pubTimestamp":1776079243,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月2日,瑞银增持绿叶制药(02186)1395.45万股,每股作价2.8547港元,总金额约3983.59万港元。增持后最新持股数目约4.03亿股,最新持股比例为10.09%。补充资料:218,500,000 of the reported long and short positions refer to the securities lending agreement executed in conjunction with the convertible bond issuance as disclosed on June 28 2023.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1583","EWH","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625940930","title":"绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2625940930","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625940930?lang=zh_cn&edition=full","pubTime":"2026-04-08 22:34","pubTimestamp":1775658898,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,本集团自主研发的创新药LY03020的中国Ⅱ期临床已完成首例患者入组。此前,LY03020亦已在美国获准开展临床试验,是本集团在中国和海外同步开发的又一款中枢神经系统治疗领域的创新药。LY03020已在早期研究中展现出积极的疗效和安全性信号。中国Ⅰ期临床研究结果表明,LY03020整体安全耐受性良好,所有治疗中出现的不良事件均为轻至中度,无EPS相关不良事件亦无严重不良事件报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03020","BK1606","159992","BK1574","BK1583","06978","02186","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134731564","title":"绿叶制药2026年3月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1134731564","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134731564?lang=zh_cn&edition=full","pubTime":"2026-04-08 21:36","pubTimestamp":1775655390,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年4月8日公布截至2026年3月31日的股份变动月报表。报告显示,本月公司已发行股本及注册股本均未发生变化,股本结构保持稳定。公司注册股本为10,000,000,000股,面值每股USD 0.02,注册股本总额USD 200,000,000。截至3月31日,普通股已发行股份数量为3,994,515,953股,与上月底一致,本月无新增发行、购回或注销,也无库藏股变化。公司无新的股份期权及股权激励计划变动。本次公告由董事祝媛媛签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"sh","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["GLD","DUST","000950","MGCmain","DZZ","159992","GDXY","GDXD","BK1191","603222","600594","1OZmain","GLTR","UGL","159831","NUGT","GLDM","159934","GDXJ","DGP","JDST","IAUM","GCmain","SGUmain","PALL","XME","300086","BK0188","USG","SGOL","IAU","600488","PHYS","JNUG","OUNZ","02162","SGCmain","02186","518880","GDXU","06978","AAAU","CEF","BK4585","QOmain","GLL","IAUI","GDX","000788","BTGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188133259","title":"异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188133259","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188133259?lang=zh_cn&edition=full","pubTime":"2026-04-02 10:01","pubTimestamp":1775095310,"startTime":"0","endTime":"0","summary":"绿叶制药(02186)今日盘中大涨5.17%,引起了市场的关注。消息面上,公司此前公布了2025年业绩。数据显示,2025年公司股东应占溢利同比增长31.12%,达到约6.19亿元,每股基本盈利为15.88分。公告称,公司收入同比增长4.1%至63.08亿元,收入增长主要归因于若干产品的销售及授权许可收入增加。这份强劲的业绩报告提振了投资者信心,推动了股价在交易时段内的显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526278","title":"港股异动 | 绿叶制药(02186)涨近5% 2025年股东应占溢利同比增长31.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526278","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624526278?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:51","pubTimestamp":1775094701,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,绿叶制药(02186)涨近5%,截至发稿,涨3.69%,报2.81港元,成交额1.05亿港元。消息面上,3月31日,绿叶制药公布2025年业绩,收入同比增长4.1%至63.08亿元,股东应占溢利为约6.19亿元,同比增长31.12%;每股基本盈利为15.88分。公告称,收入增长归因于若干产品的销售及授权许可收入增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","02186","BK1191","BK4588","BK1583","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623327566","title":"绿叶制药:2025年净利润同比增长9.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623327566","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623327566?lang=zh_cn&edition=full","pubTime":"2026-03-31 06:43","pubTimestamp":1774910601,"startTime":"0","endTime":"0","summary":"南财智讯3月31日电,绿叶制药(02186.HK)公告,截至2025年12月31日止年度,公司总收入为63.08亿元人民币,同比增长4.1%;年内溢利为7.06亿元人民币,同比增长9.4%;每股基本盈利为0.16元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313689393797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620478649","title":"绿叶制药(02186.HK)拟3月30日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620478649","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620478649?lang=zh_cn&edition=full","pubTime":"2026-03-17 21:47","pubTimestamp":1773755225,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨绿叶制药(02186.HK)宣布,公司将于2026年3月30日(星期一)举行董事会会议,藉以(其中包括)批准公司及其附属公司截至2025年12月31日止之年度业绩及其发布,并考虑派发末期股息(如有)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32075882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","BK1583","BK1606","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193127","title":"每日卖空追踪 | 绿叶制药 03月13日卖空量成交77.85万股,卖空比例为5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619193127?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:30","pubTimestamp":1773390628,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间03月13日,跌2.02%,卖空量成交77.85万股,较上一交易日减少70.8%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163409a4663ee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163409a4663ee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1606","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193172","title":"绿叶制药03月13日遭主力抛售514.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619193172?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:15","pubTimestamp":1773389742,"startTime":"0","endTime":"0","summary":"03月13日, 绿叶制药股价跌2.02%,报收2.43元,成交金额3222.2万元,换手率0.33%,振幅2.82%,量比0.71。绿叶制药今日主力资金净流出514.7万元,连续3日净流出,上一交易日主力净流出443.6万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为72.22%,平均跌幅为2.06%。该股近5个交易日下跌4.35%,主力资金累计净流出2178.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出7730.0万元,其中净流出天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313161846a46630ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313161846a46630ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02186","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618982042","title":"每日卖空追踪 | 绿叶制药 03月09日卖空量成交56.65万股,卖空比例为2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618982042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618982042?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045028,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间03月09日,跌2.77%,卖空量成交56.65万股,较上一交易日减少64.43%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163342a45ae798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163342a45ae798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02186","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618982016","title":"绿叶制药03月09日遭主力抛售946.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618982016","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618982016?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044140,"startTime":"0","endTime":"0","summary":"03月09日, 绿叶制药股价跌2.77%,报收2.46元,成交金额6547.7万元,换手率0.67%,振幅3.95%,量比1.12。绿叶制药今日主力资金净流出946.2万元,连续3日净流出,上一交易日主力净流出116.4万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为2.20%。该股近5个交易日下跌3.19%,主力资金累计净流出1562.0万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出6024.1万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161827a6b1b5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161827a6b1b5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1583","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616329367","title":"绿叶制药03月03日遭主力抛售412.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616329367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616329367?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:15","pubTimestamp":1772525750,"startTime":"0","endTime":"0","summary":"03月03日, 绿叶制药股价跌3.59%,报收2.42元,成交金额7931.4万元,换手率0.82%,振幅5.98%,量比1.63。绿叶制药今日主力资金净流出412.2万元,上一交易日主力净流出296.4万元。该股近5个交易日下跌8.68%,主力资金累计净流出3039.9万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出5412.7万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161949a69c9a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161949a69c9a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1606","02186"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luye.cn","stockEarnings":[{"period":"1week","weight":-0.0595},{"period":"1month","weight":-0.1336},{"period":"3month","weight":-0.08},{"period":"6month","weight":-0.1943},{"period":"1year","weight":0.2163},{"period":"ytd","weight":-0.0766}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.0311},{"period":"3month","weight":-0.0353},{"period":"6month","weight":-0.0222},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.0105}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.024212},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016158},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.022436},{"month":4,"riseRate":0.5,"avgChangeRate":-0.006455},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.009181},{"month":6,"riseRate":0.363636,"avgChangeRate":0.035296},{"month":7,"riseRate":0.636364,"avgChangeRate":0.018026},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.044846},{"month":9,"riseRate":0.583333,"avgChangeRate":0.045957},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00637},{"month":11,"riseRate":0.5,"avgChangeRate":0.024651},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.012685}],"exchange":"SEHK","name":"绿叶制药","nameEN":"LUYE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿叶制药,02186,绿叶制药股票,绿叶制药股票老虎,绿叶制药股票老虎国际,绿叶制药行情,绿叶制药股票行情,绿叶制药股价,绿叶制药股市,绿叶制药股票价格,绿叶制药股票交易,绿叶制药股票购买,绿叶制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}